Genfit (France) Today
| GNFT Stock | EUR 3.35 0.07 2.13% |
PerformanceVery Weak
| Odds Of DistressLow
|
Genfit is trading at 3.35 as of the 28th of March 2025, a 2.13 percent up since the beginning of the trading day. The stock's open price was 3.28. Genfit has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 28th of December 2024 and ending today, the 28th of March 2025. Click here to learn more.
Genfit SA, a biopharmaceutical company, develops therapeutic and diagnostic solutions for metabolic, inflammatory, and autoimmune or fibrotic diseases affecting primarily the liver and gastro-enterology. Genfit SA was founded in 1999 and is headquartered in Loos, France. The company has 49.82 M outstanding shares. More on Genfit
Moving against Genfit Stock
Genfit Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Genfit's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Genfit or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Chairman | JeanFrancois Mouney |
| Business Concentration | Health Care, Life Sciences Tools & Services, Biotechnology, Healthcare (View all Sectors) |
Genfit (GNFT) is traded on Euronext Paris in France and employs 134 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 202.51 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Genfit's market, we take the total number of its shares issued and multiply it by Genfit's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Genfit operates under Life Sciences Tools & Services sector and is part of Health Care industry. The entity has 49.82 M outstanding shares.
Genfit has accumulated about 69.05 M in cash with 99.92 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.65, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Genfit Probability Of Bankruptcy
Ownership AllocationGenfit has a total of 49.82 Million outstanding shares. Genfit retains 13.22 (percent) of its outstanding shares held by insiders and 2.47 (percent) owned by outside corporations. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Genfit Ownership Details
Genfit Risk Profiles
Although Genfit's alpha and beta are two of the key measurements used to evaluate Genfit's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.36 | |||
| Standard Deviation | 1.74 | |||
| Variance | 3.03 | |||
| Risk Adjusted Performance | (0.01) |
Genfit Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Genfit without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Dashboard Now
Portfolio DashboardPortfolio dashboard that provides centralized access to all your investments |
| All Next | Launch Module |
Genfit Corporate Management
Elected by the shareholders, the Genfit's board of directors comprises two types of representatives: Genfit inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Genfit. The board's role is to monitor Genfit's management team and ensure that shareholders' interests are well served. Genfit's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Genfit's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Stefanie Magner | Chief Affairs | Profile | |
| Pascal Caisey | Chief Officer | Profile | |
| Thomas Baetz | Chief Officer | Profile | |
| Pr Staels | CoFounder Board | Profile | |
| JeanChristophe Marcoux | Chief Officer | Profile | |
| Pascal Prigent | Chief Officer | Profile |
Additional Information and Resources on Investing in Genfit Stock
When determining whether Genfit is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Genfit Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Genfit Stock. Highlighted below are key reports to facilitate an investment decision about Genfit Stock:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Genfit. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For information on how to trade Genfit Stock refer to our How to Trade Genfit Stock guide.You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.